SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL

被引：0
|
作者：
McInnes, Iain B. [1 ]
Mease, Philip [2 ,3 ]
Ritchlin, Christopher T. [4 ]
Rahman, Proton [5 ]
Gottlieb, Alice B. [6 ]
Kirkham, Bruce [7 ]
机构：
[1] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Rochester, Allergy Immunol & Rheumatol Div, Rochester, NY USA
[5] Mem Univ, Fac Med, St John, NF, Canada
[6] New York Med Coll, Dept Dermatol, Valhalla, NY 10595 USA
[7] Guys & St Thomas NHS Fdn Trust, London, England
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
072
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [41] SECUKINUMAB 150 MG PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS WITH HIGH RETENTION RATE: 4-YEAR RESULTS FROM THE PHASE III TRIAL, MEASURE 2
    Marzo-Ortega, H.
    Sieper, J.
    Kivitz, A.
    Blanco, R.
    Cohen, M.
    Delicha, E. M.
    Rohrer, S.
    Richards, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1005 - 1005
  • [42] SUBCUTANEOUS SECUKINUMAB PROVIDES SUSTAINED INHIBITION OF RADIOGRAPHIC PROGRESSION IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM A PHASE 3 STUDY
    Mease, Philip
    van der Heijde, Desiree
    Landewe, Robert
    Mpofu, Shephard
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Zhu, Xuan
    Readie, Aimee
    Abrams, Ken
    Pricop, Luminita
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S10 - S10
  • [43] Subcutaneous Secukinumab Provides Sustained Inhibition of Radiographic Progression in Patients with Active Psoriatic Arthritis: 52-Week Results from a Phase 3 Study
    Mease, Philip J.
    van der Heijde, Desiree
    Landewe, Robert B. M.
    Mpofu, Shephard
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Bottcher, Elke
    Navarra, Sandra V.
    Zhu, Xuan
    Readie, Aimee
    Pricop, Luminita
    Abrams, Ken
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] SUSTAINED IMPROVEMENTS IN SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS AND REASSURING SAFETY WITH SECUKINUMAB 300 MG: 3-YEAR RESULTS FROM A PHASE 3 STUDY
    Cecena, Marco Maradiaga
    Kivitz, Alan J.
    Pavelka, Karel
    Dokoupilova, Eva
    Blanco, Ricardo
    Tahir, Hasan
    Wang, Yi
    Porter, Brian
    Stefanska, Anna
    Rohrer, Susanne
    Richards, Hanno
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S4 - S5
  • [45] Secukinumab provides sustained improvement in signs and symptoms in active psoriatic arthritis up-to 3 years: Data from FUTURE1 and FUTURE2 studies
    Nash, P.
    Gottlieb, A. Bendix
    McInnes, I.
    Mease, P.
    Delicha, E. M.
    Pellet, P.
    Kajekar, R.
    Pricop, L.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 88 - 88
  • [46] Secukinumab 150 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis with Consistent Safety Profile and High Retention Rate: 4-Year Results from a Phase III Trial
    Marzo-Ortega, Helena
    Sieper, Joachim
    Kivitz, Alan J.
    Blanco, Ricardo
    Cohen, Martin
    Delicha, Evie Maria
    Rohrer, Susanne
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] SECUKINUMAB PROVIDES IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS, REGARDLESS OF THE TIME SINCE DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM
    Strand, Vibeke
    Fitzgerald, Oliver
    Coates, Laura C.
    Walsh, Jessica A.
    Canete, Juan D.
    Nash, Peter
    Davenport, Eric
    Pricop, Luminita
    Hustache, Gregory
    Gilloteau, Isabelle
    Yocolly, Aurore
    Augustin, Matthias
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1860 - 1861
  • [48] Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
    McInnes, Iain B.
    Mease, Philip J.
    Ritchlin, Christopher T.
    Rahman, Proton
    Gottlieb, Alice B.
    Kirkham, Bruce
    Kajekar, Radhika
    Delicha, Eumorphia-Maria
    Pricop, Luminita
    Mpofu, Shephard
    RHEUMATOLOGY, 2017, 56 (11) : 1993 - 2003
  • [49] Sustained Improvements in Signs and Symptoms of Active Ankylosing Spondylitis and Reassuring Safety with Secukinumab 300mg: 3-Year Results from a Phase 3 Study
    Kivitz, Alan J.
    Pavelka, Karel
    Dokoupilova, Eva
    Blanco, Ricardo
    Maradiaga, Marco
    Tahir, Hasan
    Wang, Yi
    Porter, Brian
    Stefanska, Anna
    Rohrer, Susanne
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] Secukinumab Provides Sustained Improvements in Subgroup Analyses of Joint Tenderness and Swelling in Patients with Psoriatic Arthritis: 5-Year Results from the Phase 3 FUTURE 2 Study
    McInnes, Iain
    Chinoy, Hector
    Asquith, Darren
    White, Abigail
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345